Bristol-Myers Squibb Company announced that effective July 1, 2019 it has completed its previously announced divestment of its consumer health business, UPSA, to Taisho Pharmaceutical Co., Ltd, the largest over-the-counter drug company in Japan.
July 1, 2019
· 3 min read